Abstract
Effective pharmacological, psychosocial and other kinds of treatment are now available for schizophrenia. Often, however, neither acute nor long-term treatment can be properly applied because of insufficient compliance by both patients and doctors. Patient non-compliance is as high as 50% under outpatient conditions; potential reasons may be either illness-related (e.g. lack of insight or idiosyncratic concepts of the illness or its treatment), drug-related (e.g. intolerable side-effects) or related to inadequate treatment management (e.g. insufficient information or lack of environmental support). Non-compliance by doctors is partly due to limited adherence to treatment guidelines. To improve both patient and doctor compliance, the use of educational tools for professional health-care providers, patients and families should be generally enforced. New antipsychotics with a better risk-benefit profile with respect to clinical efficacy and side effects will probably help to overcome drug-related non-compliance.
Citations
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Martin KnappPablo Lapuerta
Jan 22, 2005·The Australian and New Zealand Journal of Psychiatry·Anne MagnusTheo Vos
Feb 20, 2002·Journal of Advanced Nursing·Sue JordanAlan Sykes
Sep 30, 2016·Health Technology Assessment : HTA·Stefan PriebeTom Burns
Jan 1, 1998·International Journal of Psychiatry in Clinical Practice·M BourinB Guitton
Aug 4, 2004·Molecular Psychiatry·S MiyamotoJ A Lieberman
Nov 7, 2000·PharmacoEconomics·E Lindström, K Bingefors
Nov 12, 2010·The Cochrane Database of Systematic Reviews·Claudia Asenjo LobosStefan Leucht
Sep 18, 2007·Human Psychopharmacology·Cengiz AkkayaSelcuk Kirli
Jul 25, 2014·Human Psychopharmacology·Takefumi SuzukiMasaru Mimura
Apr 20, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·J D BergiannakiC N Stefanis
Nov 21, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·Antonio CiudadInmaculada Gilaberte
Jan 19, 2002·Journal of Clinical Psychopharmacology·Thomas L PattersonDilip V Jeste
Nov 27, 2019·The Psychiatric Quarterly·Ayumi ShinozakiHitoshi Okamura
Apr 20, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·L de HaanL Wouters